Skip to Content

Pharmaceutical Sales 2008

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2008, listed by U.S. sales value and brand name.
Quarterly top 100 prescription sales data now available, from Q1 2011.

Top 200 Drugs for 2008 by Sales

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2007
1 Lipitor Pfizer Inc. 5,880,128 -4.6%
2 Nexium AstraZeneca 4,794,450 10.1%
3 (2) Plavix Bristol-Myers Squibb Company 3,796,221 23.1%
4 (1) Advair Diskus GlaxoSmithKline 3,572,473 5.4%
5 (1) Prevacid Takeda Pharmaceuticals U.S.A., Inc. 3,295,465 -0.6%
6 (1) Seroquel AstraZeneca 2,908,971 15.5%
7 (1) Singulair Merck 2,898,060 1.2%
8 Effexor XR Pfizer Inc. 2,657,729 7.8%
9 (24) OxyContin Purdue Pharma LP 2,502,982 139.8%
10 Actos Takeda Pharmaceuticals U.S.A., Inc. 2,447,602 9.8%
11 (2) Lexapro Actavis Pharma, Inc. 2,412,048 4.7%
12 (3) Abilify Bristol-Myers Squibb Company 2,371,795 33.1%
13 Topamax Janssen Pharmaceuticals, Inc. 2,177,348 18.5%
14 (2) Cymbalta Eli Lilly and Company 2,170,162 25.2%
15 (3) Zyprexa Eli Lilly and Company 1,748,259 10.7%
16 (6) Valtrex GlaxoSmithKline 1,684,192 20.7%
17 (6) Crestor AstraZeneca 1,676,553 22.6%
18 (6) Vytorin Merck 1,545,643 -20.3%
19 (2) Lamictal GlaxoSmithKline 1,539,101 -10.4%
20 Celebrex Pfizer Inc. 1,526,818 7.8%
21 (5) Lantus Sanofi 1,475,110 13.2%
22 (3) Levaquin Janssen Pharmaceuticals, Inc. 1,461,080 2.0%
23 (4) Adderall XR Takeda Pharmaceuticals U.S.A., Inc. 1,446,629 12.2%
24 (13) Lyrica Pfizer Inc. 1,389,205 38.9%
25 (3) Diovan Novartis Pharmaceuticals Corporation 1,283,141 14.8%
26 (4) Tricor Abbott Laboratories 1,249,299 12.9%
27 (9) Flomax Boehringer Ingelheim Pharmaceuticals, Inc. 1,236,963 23.4%
28 (14) Risperdal Janssen Pharmaceuticals, Inc. 1,221,505 -31.8%
29 (3) Diovan HCT Novartis Pharmaceuticals Corporation 1,212,308 15.3%
30 (9) Zetia Merck 1,183,627 -15.8%
31 (8) Aricept Eisai Inc. 1,149,221 16.9%
32 (15) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. 1,142,746 31.6%
33 (1) Concerta Janssen Pharmaceuticals, Inc. 1,103,973 7.1%
34 (3) Aciphex Eisai Inc. 1,052,133 -4.3%
35 (5) Imitrex Oral GlaxoSmithKline 972,778 2.3%
36 (13) Lidoderm Endo Pharmaceuticals Inc. 970,208 20.1%
37 (20) Keppra UCB, Inc. 940,941 32.8%
38 (10) Viagra Pfizer Inc. 920,051 11.5%
39 (22) Atripla Bristol-Myers Squibb Company 915,561 48.3%
40 (13) Lovenox Sanofi 913,764 22.5%
41 (43) Januvia Merck 913,501 93.7%
42 (1) Nasonex Merck 904,074 1.3%
43 (2) Ambien CR Sanofi 865,719 -1.2%
44 (10) Provigil Cephalon, Inc. 846,089 13.6%
45 (13) Geodon Oral Pfizer Inc. 797,100 19.9%
46 (16) Truvada Gilead Sciences, Inc. 775,787 28.0%
47 (8) Lunesta Sepracor Inc. 771,019 8.2%
48 (2) Enbrel Amgen Inc. 763,927 -12.7%
49 (1) Actonel Actavis Pharma, Inc. 714,977 -9.6%
50 (13) CellCept Genentech, Inc. 711,530 18.7%
51 (14) Humalog Eli Lilly and Company 702,798 18.7%
52 (8) Detrol LA Pfizer Inc. 696,934 9.6%
53 (13) Depakote ER Abbott Laboratories 692,472 20.0%
54 (5) Cozaar Merck 690,028 5.8%
55 (9) Pulmicort Respules AstraZeneca 651,024 9.9%
56 (14) Niaspan Abbott Laboratories 638,816 16.9%
57 (19) Wellbutrin XL Bausch Health Companies Inc. 613,694 -38.2%
58 (7) Chantix Pfizer Inc. 605,323 -20.8%
59 (13) Budeprion XL Teva Pharmaceuticals USA, Inc. 595,206 10.8%
60 (11) Byetta Amylin Pharmaceuticals, Inc. 594,736 9.9%
61 (69) Yaz Bayer HealthCare Pharmaceuticals Inc. 585,421 129.9%
62 (17) Prograf Astellas Pharma US, Inc. 584,703 13.3%
63 (20) Namenda Actavis Pharma, Inc. 582,468 18.9%
64 (16) Arimidex AstraZeneca 568,846 12.3%
65 (9) Combivent Boehringer Ingelheim Pharmaceuticals, Inc. 558,351 4.6%
66 (20) Cialis Eli Lilly and Company 555,080 22.5%
67 (10) Flovent HFA GlaxoSmithKline 553,050 6.1%
68 (57) Protonix Pfizer Inc. 552,903 -74.1%
69 (1) Premarin Tabs Pfizer Inc. 548,917 -1.5%
70 (50) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 531,808 88.4%
71 (11) Hyzaar Merck 528,401 5.7%
72 (19) ProAir HFA Teva Pharmaceuticals USA, Inc. 527,655 25.3%
73 (14) Reyataz Bristol-Myers Squibb Company 519,398 18.4%
74 (19) Benicar HCT Daiichi Sankyo 515,213 24.4%
75 (6) Synthroid Abbott Laboratories 514,887 -6.0%
76 (47) Avandia GlaxoSmithKline 513,715 -53.7%
77 (19) Boniva Genentech, Inc. 512,179 26.7%
78 (5) Strattera Eli Lilly and Company 511,612 -4.5%
79 () Polymagma Plain 507,096 NA
80 (2) Skelaxin Elan Corporation plc 501,310 -3.1%
81 Evista Eli Lilly and Company 499,924 -0.7%
82 (10) Asacol Actavis Pharma, Inc. 463,747 10.2%
83 (16) Depakote Abbott Laboratories 456,909 -20.4%
84 (4) Xalatan Pfizer Inc. 456,321 5.9%
85 Humira Abbott Laboratories 455,911 -1.4%
86 (16) Benicar Daiichi Sankyo 455,408 23.2%
87 (12) Gleevec Novartis Pharmaceuticals Corporation 450,576 17.2%
88 (15) AndroGel Abbott Laboratories 441,168 20.5%
89 (26) Enbrel Sureclick Amgen Inc. 433,792 47.9%
90 Avelox Bayer HealthCare Pharmaceuticals Inc. 428,793 1.0%
91 (3) Fentanyl Oral Citrate 423,743 3.8%
92 (39) Lovaza GlaxoSmithKline 417,542 65.2%
93 (20) RenaGel Genzyme Corporation 408,552 39.2%
94 (4) Avapro Bristol-Myers Squibb Company 405,557 5.4%
95 (67) Humira Pen Abbott Laboratories 381,397 99.4%
96 () Vyvanse Takeda Pharmaceuticals U.S.A., Inc. 374,990 486.1%
97 (3) Kaletra Abbott Laboratories 373,122 0.0%
98 (6) Xopenex Akorn, Inc. 371,995 4.9%
99 (13) Copaxone Accredo Health Group, Inc. 370,479 22.1%
100 (21) Avodart GlaxoSmithKline 364,706 29.6%
101 (13) Femara Novartis Pharmaceuticals Corporation 360,993 23.0%
102 (5) Avalide Bristol-Myers Squibb Company 355,748 8.2%
103 (2) Ortho Tri-Cyclen Lo Janssen Pharmaceuticals, Inc. 350,375 -5.7%
104 (23) Sensipar Amgen Inc. 348,365 30.8%
105 (13) Aldara Medicis Pharmaceutical Corporation 347,587 20.9%
106 (10) NovoLog Mix 70/30 Novo Nordisk 347,106 18.7%
107 (18) Restasis Actavis Pharma, Inc. 339,110 23.4%
108 (24) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc. 335,293 34.2%
109 (33) Yasmin 28 Bayer HealthCare Pharmaceuticals Inc. 328,905 -37.7%
110 (33) Solodyn Medicis Pharmaceutical Corporation 316,079 40.8%
111 () Lantus SoloSTAR Sanofi 315,946 829.5%
112 (11) Norvir Abbott Laboratories 311,245 13.1%
113 (20) Focalin XR Novartis Pharmaceuticals Corporation 310,010 24.5%
114 (26) Actoplus Met Takeda Pharmaceuticals U.S.A., Inc. 301,258 31.1%
115 (37) Vesicare Astellas Pharma US, Inc. 299,147 45.5%
116 (3) Forteo Eli Lilly and Company 291,621 3.3%
117 (7) Allegra-D 12 Hour Sanofi 288,202 -9.0%
118 (13) Procrit Janssen Biotech, Inc. 287,898 -18.5%
119 (11) Nasacort AQ Sanofi 285,359 -10.4%
120 (8) Tarceva Astellas Pharma US, Inc. 276,875 4.9%
121 (12) Combivir GlaxoSmithKline 275,844 -13.3%
122 () Tamiflu Genentech, Inc. 275,121 138.3%
123 (3) Avonex Biogen 273,303 2.4%
124 (13) NuvaRing Merck 267,259 15.9%
125 (74) Coreg CR GlaxoSmithKline 265,844 83.5%
126 (10) Epzicom GlaxoSmithKline 265,252 15.0%
127 () Levemir Novo Nordisk 256,142 103.5%
128 (17) Duragesic Janssen Pharmaceuticals, Inc. 251,699 -17.8%
129 (31) Risperdal Consta Janssen Pharmaceuticals, Inc. 250,948 29.5%
130 (5) Zyvox Pfizer Inc. 249,712 5.6%
131 (36) Tussionex Sanofi 246,583 37.5%
132 () Invega Janssen Pharmaceuticals, Inc. 246,052 146.4%
133 (109) Fosamax Merck 244,850 -81.9%
134 (29) Kadian Actavis Pharma, Inc. 244,504 27.9%
135 (23) Levitra Bayer HealthCare Pharmaceuticals Inc. 239,860 21.4%
136 (28) Differin Galderma Laboratories, L.P. 239,747 27.4%
137 (9) Astelin Meda U.S. 239,404 9.1%
138 (3) Lumigan Actavis Pharma, Inc. 238,436 5.1%
139 () Symbicort AstraZeneca 237,955 683.9%
140 () Janumet Merck 237,426 379.2%
141 (15) Xeloda Genentech, Inc. 236,302 17.3%
142 (25) Clarinex Merck 233,417 -19.2%
143 () Proventil HFA Merck 227,833 66.4%
144 (9) Humalog Mix 75/25 Pn 226,996 11.1%
145 (2) BenzaClin Sanofi 225,984 6.0%
146 (5) Vigamox Alcon 220,720 6.6%
147 (8) Fosamax Plus D Merck 218,738 -4.9%
148 (21) Maxalt Merck 218,686 23.7%
149 (15) Cosopt Akorn, Inc. 218,315 -10.1%
150 (55) Requip GlaxoSmithKline 213,127 -47.7%
151 (3) Relpax Pfizer Inc. 213,123 0.3%
152 (23) Patanol Alcon 211,608 -18.2%
153 (3) Casodex AstraZeneca 210,830 1.6%
154 (22) Welchol Daiichi Sankyo 209,309 29.4%
155 (17) Ciprodex Otic Alcon 207,845 19.3%
156 (7) Viread Gilead Sciences, Inc. 207,458 -1.6%
157 (8) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc. 204,665 9.2%
158 () Loestrin 24 Fe Allergan plc 200,272 42.0%
159 (15) Thalomid Bristol-Myers Squibb Company 198,528 -10.9%
160 (6) Alphagan P Actavis Pharma, Inc. 195,794 5.2%
161 (2) Endocet Endo Pharmaceuticals Inc. 194,559 0.3%
162 () Revlimid Bristol-Myers Squibb Company 194,505 99.8%
163 (39) Avandamet GlaxoSmithKline 192,785 -29.9%
164 (13) Maxalt MLT 192,378 19.0%
165 (109) Altace King Pharmaceuticals, Inc. 191,053 -73.1%
166 (11) Budeprion SR Teva Pharmaceuticals USA, Inc. 188,956 -6.2%
167 (16) Pegasys Genentech, Inc. 188,011 20.5%
168 (16) Ultram ER Janssen Pharmaceuticals, Inc. 185,318 19.2%
169 (25) Fentora Cephalon, Inc. 185,244 25.6%
170 (8) Asmanex Merck 185,244 14.9%
171 (29) Rhinocort Aqua AstraZeneca 184,397 -18.3%
172 (1) Temodar Merck 183,005 5.5%
173 (18) Micardis HCT Abbott Laboratories 180,407 21.8%
174 () Sotret Ranbaxy Pharmaceuticals Inc. 176,782 35.3%
175 (21) Trizivir GlaxoSmithKline 176,538 -13.1%
176 (19) Enablex Actavis Pharma, Inc. 176,293 19.6%
177 () Isentress Merck 175,457 >999
178 (4) Tobradex Alcon 175,251 1.4%
179 (104) Trileptal Novartis Pharmaceuticals Corporation 170,422 -68.0%
180 (23) Sustiva Bristol-Myers Squibb Company 169,984 -15.0%
181 () Amitiza Takeda Pharmaceuticals U.S.A., Inc. 169,610 41.3%
182 () Micardis Boehringer Ingelheim Pharmaceuticals, Inc. 165,979 18.7%
183 (3) Zovirax Topical GlaxoSmithKline 164,974 8.6%
184 () Ocella Teva Pharmaceuticals USA, Inc. 164,399 NA
185 () Propecia Merck 163,166 13.7%
186 () Taclonex Warner Chilcott 161,674 23.4%
187 (49) Actiq Abbott Laboratories 161,532 -29.8%
188 () Valcyte Genentech, Inc. 160,605 15.3%
189 (7) Klor-Con Sandoz Inc. 159,584 0.2%
190 (11) Atacand AstraZeneca 159,583 -0.7%
191 () Doryx Actavis Pharma, Inc. 158,466 20.4%
192 () Veramyst GlaxoSmithKline 158,347 289.8%
193 (4) Avinza King Pharmaceuticals, Inc. 157,224 7.9%
194 (1) Allegra-D 24 Hour Sanofi 156,445 5.7%
195 () Opana ER Endo Pharmaceuticals Inc. 155,662 126.7%
196 () Zomig AstraZeneca 153,913 6.7%
197 () Humulin 70/30 Eli Lilly and Company 153,026 7.2%
198 Prempro Pfizer Inc. 152,633 5.4%
199 (9) Humulin N Eli Lilly and Company 152,147 1.5%
200 () Xopenex HFA Sepracor Inc. 151,919 25.8%
All Others 26,307,000 -15.0%

Source: Verispan, VONA

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012